Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sequential gene editing in primary immune cells

Sequential gene editing in primary immune cells

US Patent 11674155 · Granted Jun 13, 2023

Estimated economic value: $937,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeted gene insertion for improved immune cells therapy2025
Method for improving production of car T cells2025
Method for generating t-cells compatible for allogenic transplantation2025
Method for generating t-cells compatible for allogenic transplantation2025
Targeted gene integration of CRS inhibitor genes for improved immune cells thera2025
Targeted gene integration of NK inhibitors genes for improved immune cells thera2025
Cellular immunotherapy for repetitive administration2024
Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclea2024
Universal anti-CD22 chimeric antigen receptor engineered immune cells2024
Chimeric antigen receptors targeting B-cell maturation antigen2024
Engineered immune cells resistant to tumor microenvironment2024
Targeted gene insertion for improved immune cells therapy2024